Charles Schwab
NVRO

Charles Schwab’s NEVRO CORP. NVRO Stock Holding History

Charles Schwab’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-301,645
Closed -$1.76M – 3620
2025
Q1 		$1.76M Sell
301,645
-12,836
-4% -$67.6K ﹤0.01% 2652
2024
Q4 		$1.17M Buy
314,481
+10,806
+4% +$49.9K ﹤0.01% 2854
2024
Q3 		$1.7M Buy
303,675
+11,369
+4% +$79.5K ﹤0.01% 2755
2024
Q2 		$2.46M Buy
292,306
+43,412
+17% +$463K ﹤0.01% 2633
2024
Q1 		$3.59M Sell
248,894
-31,634
-11% -$523K ﹤0.01% 2406
2023
Q4 		$6.04M Buy
280,528
+3,860
+1% +$68.9K ﹤0.01% 2225
2023
Q3 		$5.32M Buy
276,668
+9,846
+4% +$210K ﹤0.01% 2225
2023
Q2 		$6.78M Buy
266,822
+4,231
+2% +$122K ﹤0.01% 2088
2023
Q1 		$9.49M Buy
262,591
+433
+0.2% +$15.2K ﹤0.01% 1899
2022
Q4 		$10.4M Buy
262,158
+6,941
+3% +$289K ﹤0.01% 1833
2022
Q3 		$11.9M Buy
255,217
+6,168
+2% +$286K ﹤0.01% 1725
2022
Q2 		$10.9M Sell
249,049
-4,133
-2% -$227K ﹤0.01% 1796
2022
Q1 		$18.3M Buy
253,182
+7,237
+3% +$522K 0.01% 1613
2021
Q4 		$19.9M Buy
245,945
+3,314
+1% +$332K 0.01% 1582
2021
Q3 		$28.2M Sell
242,631
-12,774
-5% -$1.67M 0.01% 1286
2021
Q2 		$42.3M Buy
255,405
+5,349
+2% +$835K 0.01% 984
2021
Q1 		$34.9M Buy
250,056
+16,778
+7% +$2.74M 0.01% 1079
2020
Q4 		$40.4M Buy
233,278
+2,763
+1% +$447K 0.02% 916
2020
Q3 		$32.1M Sell
230,515
-5,721
-2% -$764K 0.01% 909
2020
Q2 		$28.2M Buy
236,236
+44,222
+23% +$5.25M 0.01% 938
2020
Q1 		$19.2M Buy
192,014
+3,795
+2% +$457K 0.01% 1045
2019
Q4 		$22.1M Buy
188,219
+4,073
+2% +$403K 0.01% 1130
2019
Q3 		$15.8M Buy
184,146
+7,365
+4% +$557K 0.01% 1299
2019
Q2 		$11.5M Buy
176,781
+4,801
+3% +$299K 0.01% 1511
2019
Q1 		$10.8M Buy
171,980
+7,482
+5% +$352K 0.01% 1542
2018
Q4 		$6.4M Buy
164,498
+736
+0.4% +$32.7K ﹤0.01% 1751
2018
Q3 		$9.34M Buy
163,762
+16,463
+11% +$1.03M 0.01% 1685
2018
Q2 		$11.8M Buy
147,299
+9,173
+7% +$761K 0.01% 1482
2018
Q1 		$12M Buy
138,126
+7,139
+5% +$576K 0.01% 1369
2017
Q4 		$9.04M Buy
130,987
+345
+0.3% +$27.6K 0.01% 1548
2017
Q3 		$11.9M Buy
130,642
+24,044
+23% +$2.06M 0.01% 1296
2017
Q2 		$7.93M Buy
106,598
+11,893
+13% +$953K 0.01% 1511
2017
Q1 		$8.87M Buy
94,705
+9,405
+11% +$852K 0.01% 1394
2016
Q4 		$6.2M Buy
85,300
+4,216
+5% +$361K 0.01% 1595
2016
Q3 		$8.46M Buy
81,084
+16,338
+25% +$1.48M 0.01% 1285
2016
Q2 		$4.78M Buy
64,746
+11,752
+22% +$798K 0.01% 1591
2016
Q1 		$2.98M Buy
52,994
+950
+2% +$56K ﹤0.01% 1834
2015
Q4 		$3.51M Buy
52,044
+6,248
+14% +$335K ﹤0.01% 1747
2015
Q3 		$2.13M Buy
45,796
+10,627
+30% +$515K ﹤0.01% 2035
2015
Q2 		$1.89M Buy
35,169
+17,519
+99% +$892K ﹤0.01% 2136
2015
Q1 		$846K Buy
17,650
+812
+5% +$35.2K ﹤0.01% 2439
2014
Q4 		$652K Buy
+16,838
New +$530K ﹤0.01% 2524

Other funds holding NVRO

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Charles Schwab's NVRO Position: Q2 2025 in Review

Charles Schwab sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 301,645 shares — an estimated $1.76M sold.

Charles Schwab first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $42.3M in Q2 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Charles Schwab reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Charles Schwab sold 301,645 NEVRO CORP. shares in Q2 2025, an estimated $1.76M.
  • Charles Schwab first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
  • Charles Schwab's NEVRO CORP. position peaked at $42.3M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.